Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19
Condition: Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection) Intervention: Other: convalescent plasma application to SARS-CoV-2 infected patients Sponsor: University Hospital, Basel, Switzerland Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Antiviral Therapy | Coronavirus | COVID-19 | Hospitals | Infectious Diseases | Research | SARS | Switzerland Health